SNAREs are small coiled-coil proteins required for specific membrane fusion events in eukaryotic cells. Recent evidence points to the existence of an inhibitory class of SNAREs, i-SNAREs, which prevent incorrect fusions from occurring, adding a further layer of regulation to the process of membrane docking and fusion. Nevertheless, some doubts have been raised over the extent to which SNARE proteins regulate specific membrane fusion. Non-cognate SNARE complexes are able to form in solution, a situation at first glance incompatible with a role for SNARE proteins in determining the specificity of membrane transport [9-11]. The Golgi-localised t-SNARE Sed5, for example, has been shown to associate with a number of different SNARE proteins, and only a few of these complexes are able to promote membrane fusion [11-13].
actually serve to enhance the specificity of membrane fusion by preventing unwanted fusion events. These findings may also be significant in the context of another problem that cells face: turning information in the form of molecules distributed in continuous gradients, such as SNAREs, into sharp compartmental boundaries. The cis-and trans-Golgi SNAREs, although enriched in their respective compartments, are actually distributed throughout the Golgi stack [15] , superficially at odds with a function in specific membrane fusion.
So how is specific target recognition and membrane fusion achieved? Rothman and colleagues [14] postulated that the non-cognate SNARE complexes, which are non-fusogenic in the in vitro liposome fusion assay, might be an indication of the existence of inhibitory, or i-SNAREs. In an exhaustive series of experiments carried out with yeast Golgi SNARE proteins, they showed that certain SNAREs were able to inhibit fusion when titrated into assays containing a fusion-competent set of v-SNAREs and t-SNAREs. A fusion assay recreating the cis-Golgi SNAREpinconsisting of the t-SNAREs Sed5, Sec22 and Bos1 on one liposome and the v-SNARE Bet1 on the otherwas inhibited by the addition to the t-SNARE liposome of the trans-Golgi-localised t-SNARE Gos1, the transGolgi network-localised t-SNARE Tlg1 or the trans-Golgi v-SNARE Sft1. Other SNARE proteins had no such effect. Conversely, a fusion assay modelling the transGolgi SNAREpin -the t-SNAREs Sed5, Ykt6 and Gos1, and the v-SNARE Sft1 -was inhibited by the cis-Golgi v-SNARE Bet1 or the cis-Golgi t-SNAREs Bos1 and Sec22, as well as by Tlg1. Thus, components of the cisGolgi fusion machinery are inhibited by components of the trans-Golgi machinery and vice versa ( Figure 1A) .
The potential physiological relevance of these observations is supported by a new study on the distribution of SNARE proteins across the mammalian Golgi stack [15] . Cis-Golgi v-SNARE and t-SNAREs are concentrated at the cis-face of the stack and decrease in concentration across successive cisternae towards the trans-face. The trans-Golgi v-SNARE also displays a concentration gradient, this time with the highest concentration at the trans-face. Surprisingly, the transGolgi t-SNARE appears to have an even distribution throughout the Golgi stack [15] . Thus, components of the cis-Golgi SNAREpin are mainly present at the cisGolgi, where they greatly outnumber components of the trans-Golgi SNAREpin. This would not only favour the fusion of vesicles targeted to the cis-Golgi, but also inhibit the fusion of vesicles meant to target to the trans-Golgi. A similar situation in reverse would exist at the trans-face of the Golgi stack. Thus the continuous gradient of SNAREs may be fine-tuned to create sharp compartmental boundaries ( Figure 1B) .
With the aid of these data, Varlamov et al. [14] constructed artificial target liposomes designed to mimic the SNARE compositions of the individual cisternae within the Golgi apparatus. They then tested the ability of cis-or trans-targeted liposomes, analogous to vesicles, to fuse with these Golgi-mimicking target liposomes, analogous to cisternae. As expected, cis-targeted liposomes showed a clear preference for fusing with the cis-most cisternae. Fusion with the trans-most cisternae was only 3% that of fusion with the cis-most cisternae. But if the i-SNAREs Gos1 and Sft1 were removed from the trans-cisternae, fusion increased over ten-fold to 40%, despite the presence of only a small amount of cis-Golgi t-SNAREs in the trans-cisternae.
Again, the opposite result was obtained when the fusion of trans-targeted liposomes was measured. Fusion was low with liposomes mimicking the ciscisternae unless the i-SNAREs Bos1 and Bet1 were removed from the reaction, in which case fusion of the trans-targeted liposome with the cis-most cisternae increased by between five-and ten-fold [14] . Thus, iSNAREs can increase the specificity of membrane targeting by inhibiting v-SNAREs and t-SNAREs outside the compartments in which their function is required.
What is the mode of action of the i-SNAREs? In theory, they could act by competing with either the cognate v-SNARE or t-SNARE during SNAREpin formation to form a non-cognate, non-fusogenic SNARE complex, or by binding to the tetrameric SNAREpin and preventing it from driving membrane fusion. In the case of the cis-Golgi SNAREpin, incorporating increased amounts of the cis-Golgi t-SNARE Bos1 into the target liposomes reversed inhibition of fusion by the i-SNAREs Gos1, Tlg1 and Sft1 [14] . Accordingly, SNARE complexes consisting of the cis-Golgi t-SNAREs Sed5 and Sec22 and the i-SNAREs Gos1, Tlg1 and Sft1 can form in solution but are non-fusogenic when incorporated into liposomes [12] [13] [14] . This suggests that these iSNAREs act by competing with Bos1 for incorporation into a non-functional or pseudo t-SNARE complex in the target membrane. i-SNAREs that inhibit the trans-Golgi SNAREpin, Tlg1 and Bet1, do not appear to act in a similar fashion, as their action could not be prevented by increasing the amounts of trans-Golgi t-SNAREs to the target liposome [14] .
It is unclear, therefore, whether all i-SNAREs use the same mechanism to prevent unwanted fusion events. Answering this question will require a detailed investigation of the nature of i-SNARE complexes formed in membranes, and of the topological restrictions on their function, for example whether they act in both vesicle and target membranes. Another issue that remains to be elucidated is the mechanism of i-SNARE complex recycling. Cognate SNAREpins are disassembled following the fusion reaction by the action of the ATPase NSF and its cofactor α α-SNAP. Non-cognate i-SNARE complexes are also reported to be substrates for NSF (unpublished data in [14] ), but it is too early to say if this differs in any way from cognate SNAREpin disassembly.
This new research extends our view of the importance of SNARE proteins in maintaining the integrity and function of membrane compartments. The developing picture is one of different sets of SNARE proteins defining distinct membrane sub-domains within the Golgi by regulating membrane fusion in both a positive and negative fashion. The existence of nonfusogenic SNARE complexes containing non-Golgi SNARE proteins suggests that i-SNAREs may also exist on other organelles within the cell negatively regulating other membrane transport steps, for example between early and late endosomes. SNARE proteins do not act alone to control specific membrane docking and fusion in vivo. There is an abundance of evidence to suggest that Rab proteins and their effectors act upstream of SNAREs to regulate the initial stages of membrane tethering [6, 7] , and it has been suggested that these proteins too are involved in defining membrane subdomains [16] . It is tempting to speculate that the principle of negative regulation might also apply to these proteins with 'antitethering' factors being recruited to fend off incoming vesicles from incorrect targets [7] . It is also possible that the Rab/effector systems may be in communication with SNARE proteins, to favour the incorporation of cognate SNAREs rather than i-SNAREs into the SNAREpin. One advantage of such a system would be to decrease the number of unproductive, non-fusogenic SNARE complexes forming by inhibiting vesicle targeting at an earlier stage.
The elucidation of the role of i-SNAREs in fine-tuning the specificity of membrane fusion brings us a step further in understanding how membrane transport is controlled and targeted. 
